Patents by Inventor Andrew Charles Vendel

Andrew Charles Vendel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-HUMAN LAIR1 ANTIBODIES
    Publication number: 20240101670
    Abstract: The present disclosure relates to antibodies that bind human LAIR1 (“anti-human LAIR1 antibodies” or “anti-human LAIR1 antibodies”), compositions comprising such anti-human LAIR1 antibodies, and methods of using such anti-human LAIR1 antibodies.
    Type: Application
    Filed: September 15, 2023
    Publication date: March 28, 2024
    Inventors: Julian DAVIES, Scott Charles POTTER, Andrew Charles VENDEL, Wei WANG, Reid Martin Renny FELDMAN, Shireen Syrah KHAN, Monica MACAL, Maria Elena AYALA RAMIREZ
  • BTLA agonist antibodies and uses thereof
    Patent number: 11396545
    Abstract: Antibodies which bind BTLA, and methods of using same, are provided, said antibodies are useful as agents for treating conditions associated with autoimmune disease including treating lupus.
    Type: Grant
    Filed: February 17, 2020
    Date of Patent: July 26, 2022
    Assignee: Eli Lilly and Company
    Inventors: Shane Krummen Atwell, Andrew Charles Vendel, Victor H. Obungu
  • BTLA AGONIST ANTIBODIES AND USES THEREOF
    Publication number: 20200239578
    Abstract: Antibodies which bind BTLA, and methods of using same, are provided, said antibodies are useful as agents for treating conditions associated with autoimmune disease including treating lupus.
    Type: Application
    Filed: February 17, 2020
    Publication date: July 30, 2020
    Inventors: Shane Krummen Atwell, Andrew Charles Vendel, Victor H. Obungu
  • BTLA agonist antibodies and uses thereof
    Patent number: 10604573
    Abstract: Antibodies which bind BTLA, and methods of using same, are provided, said antibodies are useful as agents for treating conditions associated with autoimmune disease including treating lupus.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: March 31, 2020
    Assignee: Eli Lilly and Company
    Inventors: Shane Krummen Atwell, Andrew Charles Vendel, Victor H. Obungu
  • BTLA AGONIST ANTIBODIES AND USES THEREOF
    Publication number: 20180334502
    Abstract: Antibodies which bind BTLA, and methods of using same, are provided, said antibodies are useful as agents for treating conditions associated with autoimmune disease including treating lupus.
    Type: Application
    Filed: May 11, 2018
    Publication date: November 22, 2018
    Inventors: Shane Krummen Atwell, Andrew Charles Vendel, Victor H. Obungu
  • Anti-TNF-anti-IL-17 bispecific antibodies
    Patent number: 9416182
    Abstract: Bispecific antibodies are provided that specifically bind both Tumor Necrosis Factor alpha (TNF?) and Interleukin-17 (IL-17). The bispecific antibodies of the invention are useful for treating various autoimmune diseases, including Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), and Ankylosing Spondylitis (AS).
    Type: Grant
    Filed: March 4, 2014
    Date of Patent: August 16, 2016
    Assignee: Eli Lilly and Company
    Inventors: Barrett Allan, Andrew Lawrence Glasebrook, Jirong Lu, Ying Tang, Derrick Ryan Witcher, Donmienne Doen Mun Leung, Pia Pauliina Yachi, Andrew Charles Vendel
  • ANTI-TNF-ANTI-IL-17 BISPECIFIC ANTIBODIES
    Publication number: 20140255406
    Abstract: Bispecific antibodies are provided that specifically bind both Tumor Necrosis Factor alpha (TNF?) and Interleukin-17 (IL-17). The bispecific antibodies of the invention are useful for treating various autoimmune diseases, including Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), and Ankylosing Spondylitis (AS).
    Type: Application
    Filed: March 4, 2014
    Publication date: September 11, 2014
    Applicant: Eli Lilly and Company
    Inventors: Barrett Allan, Andrew Lawrence Glasebrook, Jirong Lu, Ying Tang, Derrick Ryan Witcher, Donmienne Doen Mun Leung, Pia Pauliina Yachi, Andrew Charles Vendel